358 related articles for article (PubMed ID: 25483510)
1. Vaccination against respiratory Pseudomonas aeruginosa infection.
Grimwood K; Kyd JM; Owen SJ; Massa HM; Cripps AW
Hum Vaccin Immunother; 2015; 11(1):14-20. PubMed ID: 25483510
[TBL] [Abstract][Full Text] [Related]
2. Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
Gomi R; Sharma A; Wu W; Sung B; Worgall S
Vaccine; 2017 Dec; 35(51):7174-7180. PubMed ID: 29126807
[TBL] [Abstract][Full Text] [Related]
3. Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From
Sen-Kilic E; Blackwood CB; Boehm DT; Witt WT; Malkowski AC; Bevere JR; Wong TY; Hall JM; Bradford SD; Varney ME; Damron FH; Barbier M
Front Immunol; 2019; 10():2497. PubMed ID: 31708925
[No Abstract] [Full Text] [Related]
4. Understanding
Sainz-Mejías M; Jurado-Martín I; McClean S
Cells; 2020 Dec; 9(12):. PubMed ID: 33291484
[No Abstract] [Full Text] [Related]
5. Immune responses in the airways by nasal vaccination with systemic boosting against Pseudomonas aeruginosa in chronic lung disease.
Sorichter S; Baumann U; Baumgart A; Walterspacher S; von Specht BU
Vaccine; 2009 May; 27(21):2755-9. PubMed ID: 19366571
[TBL] [Abstract][Full Text] [Related]
6. Genome-Based Approach Delivers Vaccine Candidates Against
Bianconi I; Alcalá-Franco B; Scarselli M; Dalsass M; Buccato S; Colaprico A; Marchi S; Masignani V; Bragonzi A
Front Immunol; 2018; 9():3021. PubMed ID: 30687303
[TBL] [Abstract][Full Text] [Related]
7. Recent developments for Pseudomonas vaccines.
Sharma A; Krause A; Worgall S
Hum Vaccin; 2011 Oct; 7(10):999-1011. PubMed ID: 21941090
[TBL] [Abstract][Full Text] [Related]
8. Mucosal and systemic antibody responses to potential Pseudomonas aeruginosa vaccine protein antigens in young children with cystic fibrosis following colonization and infection.
Moore R; Kyd JM; Carzino R; Armstrong D; Grimwood K; Otczyk DC; Cripps AW
Hum Vaccin Immunother; 2013 Mar; 9(3):506-14. PubMed ID: 23249482
[TBL] [Abstract][Full Text] [Related]
9. Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection.
Kamei A; Coutinho-Sledge YS; Goldberg JB; Priebe GP; Pier GB
Infect Immun; 2011 Mar; 79(3):1289-99. PubMed ID: 21149583
[TBL] [Abstract][Full Text] [Related]
10. Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa.
Zhang M; Sun C; Gu J; Yan X; Wang B; Cui Z; Sun X; Tong C; Feng X; Lei L; Han W
Microbiol Immunol; 2015 Sep; 59(9):533-44. PubMed ID: 26249788
[TBL] [Abstract][Full Text] [Related]
11. Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: a clinical trial of immunogenicity in lower airways of human volunteers.
Bumann D; Behre C; Behre K; Herz S; Gewecke B; Gessner JE; von Specht BU; Baumann U
Vaccine; 2010 Jan; 28(3):707-13. PubMed ID: 19887136
[TBL] [Abstract][Full Text] [Related]
12. Vaccines and immunotherapy against Pseudomonas aeruginosa.
Döring G; Pier GB
Vaccine; 2008 Feb; 26(8):1011-24. PubMed ID: 18242792
[TBL] [Abstract][Full Text] [Related]
13. Defining the Mechanistic Correlates of Protection Conferred by Whole-Cell Vaccination against Pseudomonas aeruginosa Acute Murine Pneumonia.
Sen-Kilic E; Blackwood CB; Huckaby AB; Horspool AM; Weaver KL; Malkowski AC; Witt WT; Bevere JR; Damron FH; Barbier M
Infect Immun; 2021 Jan; 89(2):. PubMed ID: 33199354
[No Abstract] [Full Text] [Related]
14. Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection.
Lang AB; Rüdeberg A; Schöni MH; Que JU; Fürer E; Schaad UB
Pediatr Infect Dis J; 2004 Jun; 23(6):504-10. PubMed ID: 15194830
[TBL] [Abstract][Full Text] [Related]
15. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
[TBL] [Abstract][Full Text] [Related]
16. Killed but metabolically active Pseudomonas aeruginosa-based vaccine induces protective humoral- and cell-mediated immunity against Pseudomonas aeruginosa pulmonary infections.
Meynet E; Laurin D; Lenormand JL; Camara B; Toussaint B; Le Gouëllec A
Vaccine; 2018 Mar; 36(14):1893-1900. PubMed ID: 29506924
[TBL] [Abstract][Full Text] [Related]
17. Vaccine strategies against Pseudomonas aeruginosa infection in the lung.
Cripps AW; Dunkley ML; Clancy RL; Kyd J
Behring Inst Mitt; 1997 Feb; (98):262-8. PubMed ID: 9382749
[TBL] [Abstract][Full Text] [Related]
18. Progress Toward the Elusive
Merakou C; Schaefers MM; Priebe GP
Surg Infect (Larchmt); 2018; 19(8):757-768. PubMed ID: 30388058
[No Abstract] [Full Text] [Related]
19. Serum albumin nanoparticles vaccine provides protection against a lethal Pseudomonas aeruginosa challenge.
Maria de Souza Morais S; Ferreira Rodigues N; Ingrid Oliveira da Silva N; Aparecido Salvador E; Rodrigues Franco I; Augusto Pires de Souza G; Henrique Cruvinel da Silva P; Gustavo Nogueira de Almeida L; Prado Rocha R; Carolina Toledo da Cunha Pereira A; Portela Ferreira G; Veras Quelemes P; Pereira de Araújo M; Fornias Sperandio F; Júnia de Souza Santos L; Assis Martins Filho O; Cosme Cotta Malaquias L; Felipe Leomil Coelho L
Vaccine; 2018 Oct; 36(43):6408-6415. PubMed ID: 30228029
[TBL] [Abstract][Full Text] [Related]
20. Vaccine development and passive immunization for Pseudomonas aeruginosa in critically ill patients: a clinical update.
Vincent JL
Future Microbiol; 2014; 9(4):457-63. PubMed ID: 24810345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
